LIBBY LEVINE: Open Payments
NPI 1659788990 · NEW YORK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$6,339 in 42 payments from 8 companies in 2025. Trend: 2023 $6,773 · 2024 $3,170 · 2025 $6,339
Consulting: $3,500Food & beverage: $1,995Travel & lodging: $844
| Company | Payments | Amount |
|---|---|---|
| Genentech USA, Inc. | 9 | $4,686 |
| Biogen, Inc. | 6 | $508 |
| TG Therapeutics, Inc. | 7 | $398 |
| Novartis Pharmaceuticals Corporation | 6 | $190 |
| Amgen Inc. | 3 | $150 |
| EMD Serono, Inc. | 3 | $148 |
| Celgene Corporation | 5 | $133 |
| Genentech, Inc. | 3 | $126 |
Products named: Ocrevus, BRIUMVI, VUMERITY, TYSABRI, KESIMPTA, UPLIZNA, ZEPOSIA, Ocrevus Zunovo.
Industry payments across NY — which companies pay providers there.
